Skip to content
Screener

Pulmonx Corporation LUNG Q2 2026 earnings

Reported July 29, 2026 · After market close

Revenue$22.8MBeat by $362.0K
EPS-$0.24Beat by $0.04
Revenue estimate$22.4M
EPS estimate-$0.28
“With a fully staffed US sales leadership team, a more focused global commercial team, and a realigned cost structure, we are confident in our ability to return to year-over-year revenue growth and drive meaningful operating leverage while advancing our longer-term strategic priorities.”
Glen French

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$21.9M
EPS estimate-$0.26

Valuation & ratios

Valuation

as of 09/16/26
See full
Market cap$82.03M+27.4%
Enterprise value$77.3M+58.1%
P/S0.9×+0.2×

FAQ

When did Pulmonx Corporation report Q2 2026 earnings?
Pulmonx Corporation (LUNG) reported Q2 2026 earnings on July 29, 2026 after market close.
What were Pulmonx Corporation's Q2 2026 revenue and EPS?
Pulmonx Corporation reported revenue of $22.8M and eps of $-0.24 for Q2 2026.
Did Pulmonx Corporation beat estimates in Q2 2026?
Revenue beat the consensus estimate of $22.4M by $362.0K. EPS beat the consensus estimate of $-0.28 by $0.04.
How did Pulmonx Corporation's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 4.6% from $23.9M a year earlier and eps grew 36.8% from $-0.38.
Where can I find Pulmonx Corporation's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001127537-26-000035) and the 10-Q periodic report (0001127537-26-000039) directly on SEC EDGAR. The filing index links above go to sec.gov.